|
Age (≤ 60 years vs. > 60 years)
|
0.945 (0.457–1.955)
|
0.880
| | |
|
Sex (male vs. female)
|
1.014 (0.492–2.090)
|
0.970
| | |
|
Primary tumor location (rectum vs. colon)
|
1.562 (0.754–3.236)
|
0.230
| | |
|
Primary tumor differentiation (poor vs. well to moderate)
|
1.601 (0.732–3.502)
|
0.160
| | |
|
T stage (4 vs. 1–3)
|
1.957 (0.964–3.973)
|
0.063
|
2.247 (1.093–4.622)
|
0.028
|
|
N stage (positive vs. negative)
|
1.139 (0.345–3.760)
|
0.831
| | |
|
Timing of metastasis (synchronous vs. metachronous)
|
1.190 (0.456–3.106)
|
0.722
| | |
|
Number of metastatic tumors (> 1 vs. 1)
|
0.930 (0.279–3.095)
|
0.906
| | |
|
Metastases diameter( > 3 cm vs. ≤ 3 cm)
|
1.625 (0.795–3.321)
|
0.183
| | |
|
Preoperative CEA (> 50 ng/mL vs. ≤ 50 ng/mL)
|
0.727 (0.334–1.585)
|
0.423
| | |
|
Preoperative CA19-9 (> 35 U/mL vs. ≤ 35 U/mL)
|
0.972 (0.444–2.129)
|
0.943
| | |
|
Preoperative chemotherapy (yes vs. no)
|
1.470 (0.687–3.148)
|
0.321
| | |
|
ACT (yes vs. no)
|
0.402 (0.188–0.858)
|
0.018
|
0.350 (0.161–0.759)
|
0.008
|
